Toggle light / dark theme

Call for Papers on the Future of Obesity

With 1 in 7 people (1.1 billion) worldwide affected by obesity,1,2 the possibility of widespread, effective medical treatment for this chronic condition has catalyzed a field previously beset by a sense of fatalism. The glucagon-like peptide-1 (GLP-1) and multiple receptor agonist peptide and nonpeptide therapies have yielded weight loss outcomes exceeding what their most ardent proponents could have imagined. Yet the availability of these novel therapeutics is limited by access and adverse effects. Perhaps even more important, their integration into an overall strategy addressing the complex biological, behavioral, socioeconomic, and environmental factors underpinning overweight and obesity is nascent at best.

In May 2026, JAMA convened patients, clinicians, scientists, and economists, as well as representatives from government and the many industries touching this pervasive and historically intractable epidemic. Their findings are summarized in “Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity,” published in this issue of JAMA. The report is a succinct summary of the biopsychosocial drivers of obesity and points the way forward through prevention measures, management approaches, and areas requiring further research.3

Building on the themes outlined in this report, JAMA is now launching a call for papers on the “future of obesity.” The call seeks papers addressing a range of topics from novel therapeutics to strategies for prevention and sustainable, comprehensive care. Published articles on these topics across JAMA Network journals will be highlighted to broaden the discourse beyond the JAMA Summit report. JAMA has an ongoing series, “Current Topics in Obesity,”4 and recently published research articles have included epidemiologic updates5 as well as trials of new therapeutics6-8 and behavioral intervention models.9, 10 The World Health Organization (WHO) guidelines on use of GLP-1 therapies for treatment of obesity was published in 2025,11 and a number of recent Perspectives and Viewpoints have commented on multimodal care for obesity, integrating exercise into GLP-1 treatment, and related topics.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.